Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement,... see more

GREY:CBICF - Post Discussion

The Canadian Bioceutical > Just bought in
View:
Post by Billmann on Dec 19, 2018 1:29am

Just bought in

I just bought in yesterday and was wondering do I still get Ianthus shares when they merge? What's the time limit to buy in?
Comment by Billmann on Dec 19, 2018 9:02am
sorry I meant mpx-i shares
Comment by MoneyIsComing on Dec 20, 2018 9:13am
This post has been removed in accordance with Community Policy
Comment by MoneyIsComing on Dec 20, 2018 9:14am
This post has been removed in accordance with Community Policy
Comment by Mike411Ontario on Dec 20, 2018 7:19pm
No time limit because they are merging.  This is not like a dividend date.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities